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Abstract We reported that ecto-NAD + glycohydrolase activity 
induced upon differentiation of HL-60 cells with retinoic acid is 
localized on the extracellular domain of CD38 and that CD38 
ligation by a specific monoclonal antibody, HB-7, is followed by 
rapid tyrosine phosphorylation of cellular proteins including a 
proto-oncogene product, Cbl. In the present study, we investi- 
gated intraceHular signaling linked to the HB-7-induced Cbl 
phosphorylation in dibutyryl cAMP-treated THP-1 cells. The 
85-kDa regulatory subonit (p85) of phosphatidylinositul (PI) 3- 
kinase was immunoprecipitated with anti-Cbl antibody in a 
manner dependent on the tyrosine phosphorylation of Cbl. PI 3- 
kinase activity was also observed in the immunoprecipitated 
fractions containing tyrosine-phosphorylated Cbl. The phos- 
phorylated form of Cbl, which had been separated from the 
CD38-stimulated cells, was capable of directly binding to a 
recombinant p85 fused to glutathione S-transferase. Thus, the 
direct association of tyrosine-phosphorylated Cbl with PI 3- 
kinase, possibly leading to the kinase activation, appeared to be 
involved in intracellular signaling caused by the CD38 ligation. 
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1. Introduction 
The human cell surface antigen CD38 is a 46-kDa type II 
glycoprotein with a single transrnembrane domain [1]. Analy- 
sis of expression of CD38 is widely used as a phenotypic 
marker of differentiation or activation of human T and B 
lymphocytes [2]. We previously demonstrated that NADase 
activity induced by all-trans retinoic acid in human leukemic 
HL-60 cells is due to the extracellular domain of CD38 [3] and 
that the same molecule is able to bind hyaluronate [4]. CD38 
displayed an amino acid sequence similar to Aplysia ADP- 
ribosyl cyclase, an enzyme which catalyzes the formation of 
cyclic ADP-ribose from NAD ÷ [5]. The cyclic nucleotide has 
been considered a new mediator or modulator of Ca z+ release 
from intracellular stores insensitive to inositol 1,4,5-trisphos- 
phate [6]. Indeed, CD38 catalyzes not only the hydrolysis of 
NAD +, but also the formation and hydrolysis of cyclic ADP- 
ribose, although at much lower levels [7]. 
CD38 is considered an important regulatory molecule in the 
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immune system, as inferred from the observation that CD38 
ligation by agonistic mAbs elicits a variety of cell functions, 
including cell proliferation, lymphopoiesis, apoptosis, adhe- 
sion and cytokine production [2,8,9]. CD38 ligation by 
mAbs is believed to mimic some of the events triggered by 
the binding with a natural igand. In this regard, a cell surface 
protein with the Mr of 120000, which is predominantly pro- 
duced in endothelial cells, was recently identified as one of the 
CD38-binding proteins [10]. Quite recently, we found that 
ligation of CD38 with selected mAbs induces rapid tyrosine 
phosphorylation of cellular proteins in retinoic acid-treated 
HL-60 cells [11]. Such protein-tyrosine phosphorylation was 
also observed in mouse [12,13] and human [14] B cells and 
retinoic acid- or Bt2cAMP-treated monocytic THP-1 cells [15]. 
The tyrosine-phosphorylated proteins included phospholipase 
C-y, PI 3-kinase, Syk [14] and Btk [13] tyrosine kinases, and a 
proto-oncogene product, Cbl [11]. However, intracellular sig- 
naling associated with the CD38-dependent tyrosine phos- 
phorylation is yet to be defined. 
Cbl, one of the prominent phosphorylated proteins by 
CD38 ligation [11], is also known to be phosphorylated 
upon stimulation of T- and B-cell receptors, Fc receptors 
for IgG (FcTR), and some cytokine receptors as well [16- 
19]. The oncogene product is capable of binding to non-re- 
ceptor type tyrosine kinases, receptor-tyrosine kinases, adap- 
tor proteins, and PI 3-kinases [16-18]. Among them, a typical 
PI 3-kinase is a heterodimer with an 85-kDa regulatory (p85) 
subunit and a l l0-kDa catalytic (pl l0) subunit (for review, 
see [20-22]). p85 possesses two SH2 and one SH3 domains. 
Proteins containing a consensus motif, YXXM, bind either of 
the two SH2 domains of the p85 subunit upon its tyrosine 
phosphorylation, thereby activating the catalytic function of 
the associated p l l0  subunit. The motif, YXXM, is found in 
the intracellular domain of tyrosine kinase-type receptors and 
in tyrosine kinase-substrate proteins, such as the insulin re- 
ceptor substrate 1, polyoma middle T antigen, and Cbl. Re- 
cently, we have presented evidence suggesting that tyrosine- 
phosphorylated Cbl may communicate between FcyR-coupled 
tyrosine kinase and PI 3-kinase in Bt2cAMP-treated THP-1 
cells [19]. The association has a crucial effect upon FcyR stim- 
ulation in phagocytes [23]. Here we examined the possibility 
that tyrosine phosphorylation f Cbl by CD38 ligation might 
also result in association with PI 3-kinase. 
2. Materials and methods 
2.1. Materials 
The anti-CD38 mAb, HB-7, was purified from the culture medium 
All rights reserved. 
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of HB 136 cells as described previously [11]. GST-p85 fusion protein 
was purified from E. eoli producing the protein. The anti-PY mAb 
PY-20, polyclonal anti-p85 Ab and rabbit anti-Cbl Ab were obtained 
from Santa Cruz; 12SI-labeled protein G and [~t-a2p]ATP from Du- 
Pont/NEN; phospholipids from Avanti Polar Lipids Inc. All other 
reagents from commercial sources were of analytical grade. 
2.2. Cells 
The human monocytic ell line THP-1 obtained from the American 
Type Culture Collection was maintained in RPMI 1640 medium sup- 
plemented with 10% fetal calf serum, penicillin (100 U/ml), strepto- 
mycin (100 gg/ml) and 20 mM HEPES (pH 7.2). The cells were cul- 
tured with 0.5 mM Bt2cAMP for 72 h before use. 
2.3. Stimulation of THP-1 cells" with anti-CD38 mAb 
The cultured cells were washed twice and suspended in Krebs-Ring- 
er-HEPES buffer (134 mM NaC1, 4.7 mM KCI, 1.2 mM KH2PO4, 1.2 
mM MgSO4, 2.5 mM CaC12, 5 mM glucose, 0.2% bovine serum 
albumin, and 20 mM HEPES, pH 7.4). Aliquots (10 7 cells/0.5 ml) 
of the cell suspension were warmed to 37°C for 5 min, and stimulated 
with 2 ILtg/ml of HB-7 at 37°C for the indicated times. The reactions 
were terminated with 0.5 ml of ice-cold lysis buffer consisting of 2% 
NP-40, 4 mM NaVOz, 100 mM NaF, 40 mM HEPES (pH 7.8), 100 
units/ml of aprotinin, 2 mM PMSF, 2 mM dithiothreitol, 10 mM 
EDTA and 0.2% bovine serum albumin. 
2.4. Immunoprecipitation a d immunoblotting 
The cell lysate was precleared with preimmune IgG and protein G- 
Sepharose at 4°C for 1 h. The supernatant was incubated with appro- 
priate antibodies for more than 1 h, and for a further 1 h or a longer 
period of time with the addition of protein G-Sepharose. After re- 
peated washing, immunoprecipitates were heated at 100°C for 3 rain 
in 30 BI of the sample buffer consisting of 1% SDS, 10% glycerol, 5% 
2-mercaptoethanol, 0.02% bromophenol b ue, and 62.5 mM Tris (pH 
6.8). Solubilized peptides were then separated by SDS-PAGE on 7.5% 
slab gel and transferred electrophoretically to a polyvinylidene difluo- 
ride membrane at 2 mA/cm 2for 40 min. After blocking in 3% bovine 
serum albumin, the blot was incubated with appropriate antibodies 
and then with 12SI-labeled protein G. Where indicated (Fig. 1D), the 
blot was first incubated at 4°C for 1 h with 5 gg/ml of GST-p85 in 
Tris-buffered saline supplemented with 3% bovine serum albumin and 
then probed with anti-p85 Ab and t25I-labeled protein G to test the 
direct association of the blotted proteins with p85. Following repeated 
washing, associated radioactivity was located with a Fuji BAS2000 
bioimaging analyzer. 
2.5. Assay of  P1 3-kinase activity 
The materials associated with anti-phosphotyrosine (PY-20), anti- 
Cbl or anti-p85 were assayed for PI 3-kinase activity. The samples 
prepared as above were washed twice with a buffer consisting of 40 
mM Tris-HCl (PH 7.4) and 5 mM EDTA supplemented with 1% NP- 
40, twice with the buffer containing 0.5 M LiC1, and three times with 
the buffer containing 100 mM NaCI. Aliquots (2×10 G cells) of im- 
munoprecipitates were suspended in 0.1 ml of the reaction mixture 
consisting of 40 mM Tris-HCl (pH 7.4), 0.5 mM EGTA, 0.2 mM PI, 
0.2 mM phosphatidylserine, 5 mM MgCI2, and 0.1 mM [7-32p]ATP (2 
BCi). The reaction was allowed to proceed at 37°C for 15 min before 
termination by the addition of 20 gl of 8% HC10.j and 0.45 ml of 
chloroform/methanol (1:2, v/v). After vigorous stirring, 0.15 ml of 
chloroform and 0.15 ml of 8% HC104 was added to the mixture to 
separate the organic phase, which was washed with chloroform-satu- 
rated 0.5 M NaC1 containing 1% HCIO4 and then evaporated to 
dryness. The extract was dissolved in 30 gl of chloroform/methanol 
(9:1) to be spotted on a silica gel plate (Silica Gel 60, Merck). The 
plate was developed in chloroform/methanol/28% NHaOH/H20 
(70:100:25:15, v/v). The radioactivity in the PI-3P fraction was deter- 
mined with a Fuji BAS2000 bioimaging analyzer. 
3. Results 
Monocytic THP-1 cells were cultured with Bt2cAMP for 
3 days to produce CD38 on the cell surface [15], and the cells 
were then stimulated with an anti-CD38 mAb, HB-7. Lysate 
from the cells was subjected to immunoprecipitation with 
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Fig. ]. Association of the 85-kDa regulatory (p85) subunit of P[ 3- 
kinase with tyrosJne-phosphory]ated Cbl after stimulation of THP-1 
cells with HB-7. THP-1 cells that had been cultured with Bt2cAMP 
were stimulated with 10 Bg/ml of HB-7 at 37°C for the indicated 
times. The cell lysate was immunoprecipitated (]P) with anti-Cbl 
Ab, separated by SDS-PAGE, and analyzed by immunoblotting 
([B) with the indicated Abs (A C) as described in Section 2.4. In D, 
the samples immunoprecipitated with antJ-Cbl Ab were separated 
by SDS-PAGE and blotted to a membrane. The membrane was 
further incubated with a recombinant GST-p85 fusion protein fol- 
lowed by immunob]ottJng with anti-p85 Ab as described in Section 
2.4. The data are from a typical experiment; similar results were ob- 
tained more than three times. 
anti-Cbl Ab, and the precipitated proteins, after being sepa- 
rated by SDS-PAGE, were visualized by means of immuno- 
blotting with an anti-phosphotyrosine Ab (PY-20). As shown 
in Fig. 1A, tyrosine phosphorylation of Cbl with a Mr of 
120000 was very rapidly observed after the addition of HB- 
7; the phosphorylation occurred within 30 s, the maximum 
level being reached at 2 min, followed by a gradual decrease in 
the phosphorylation level. When the immunoblot analysis was 
performed with anti-Cbl Ab instead of PY-20, there were no 
marked differences in the immunoreactive 120-kDa Cbl 
among the various fractions, indicating that the same 
amounts of Cbl could be immunoprecipitated under the pres- 
ent conditions (Fig. 1B). The same anti-Cbl-precipitated frac- 
tions were separations by SDS-PAGE and visualized with 
anti-p85 Ab. As shown in Fig. 1C, the 85-kDa regulatory 
subunit of PI 3-kinase appeared to be present in the Cbl- 
containing fractions only upon the CD38 ligation by HB-7. 
The time course of the appearance of the immunoreactive p85 
(see Fig. 1C) was similar to that observed in the tyrosine 
phosphorylation of Cbl (see Fig. 1A), suggesting that p85 is 
capable of binding only to the tyrosine-phosphorylated form 
of Cbl, since all the precipitated fractions contained the same 
amounts of 120-kDa Cbl (see Fig. IB). 
When lysate from the anti-CD38 mAb-treated cells was first 
immunoprecipitated with anti-p85 Ab and then subjected to 
immunoblotting with anti-Cbl Ab, we could not see the im- 
munoreactive band corresponding to 120-kDa Cbl (data not 
shown). This might suggest hat only a limited amount of Cbl 
could associate with the p85 of PI 3-kinase. Alternatively, the 
anti-p85 Ab used in the present study might be unsuitable for 
the immunoprecipitation f a specific form of p85 associated 
with tyrosine-phosphorylated Cbl, probably due to the mask- 
ing of its epitopic site(s). 
The existence of a catalytic subunit of PI 3-kinase, which 
might be associated with p85, was estimated in the anti-Cbl- 
precipitated fractions by measuring the kinase activity as fop 
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Fig. 2. Association of the catalytic activity of PI 3-kinase with tyro- 
sine-phosphorylated Cbl after stimulation of THP-I cells with HB-7. 
The Bt2cAMP-treated THP-1 cells were stimulated with 10 mg/ml 
of HB-7 at 37°C for the indicated times. The cell lysate was immu- 
noprecipitated with anti-Cbl Ab and then subjected to the assay for 
PI 3-kinase as described in Section 2.5. The generation of PI-3P is 
plotted in an arbitrary unit as a function of incubation time. The 
data are from a typical experiment; similar results were obtained 
more than three times. 
lows. The precipitated fractions were incubated with PI and 
[7-32P]ATP, and radioactivity incorporated into PI 3-P was 
then separated by thin-layer chromatography. As shown in 
Fig. 2, there was a marked increase of PI 3-kinase activity 
in the immunoprecipitated fractions upon CD38 ligation by 
HB-7. The time course of the activity increase was again cor- 
related with that of tyrosine-phosphorylated Cbl (see Fig. 
1A). 
The possible association of the phosphorylated Cbl with the 
p85 subunit of PI 3-kinase was further investigated with a 
recombinant GST-p85 fusion protein. The anti-Cbl-immuno- 
precipitated fractions, after being separated by SDS-PAGE, 
were blotted to a membrane, and the membrane was further 
incubated with GST-p85. When the membrane was visualized 
with anti-p85 Ab, the p85-fusion protein was clearly observed 
at the position of 120-kDa Cbl only in the fractions contain- 
ing its phosphorylated form (Fig. 1D). Cbl contains several 
proline-rich motifs and potential tyrosine phosphorylation 
sites that might mediate its interaction with proteins posses- 
sing SH3 and SH2 domains, respectively [16-18]. Since the 
association of the two polypeptides observed in Fig. 1D ap- 
peared to be inhibited by the addition of an excess amount of 
phenylphosphate (data not shown), it is very likely that PI 3- 
kinase binds to tyrosine-phosphorylated Cbl via the SH2 do- 
main(s) of p85. 
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4. Discussion 
Our data in this communication clearly indicate that the 
tyrosine phosphorylation of a proto-oncogene product, Cbl, 
upon CD38 ligation by HB-7 results in direct association of 
Cbl with PI 3-kinase in Bt2cAMP-treated THP-I cells. PI 3- 
kinase is a lipid kinase which catalyzes phosphorylation at the 
D-3 position of the inositol ring of PI, PI 4-phosphate, and PI 
4,5-bisphosphate. The activity of this enzyme in cells increases 
upon stimulation of numerous immune inflammatory stimuli 
such as interleukin (IL-2, IL-3, IL-4, or IL-7) and granulocyte 
monocyte colony stimulating factor (GMCSF) receptors, T- 
cell receptors, B-cell antigen receptors, and Fc receptors 
[21,22]. Most of these receptors possess the consensus e- 
quence termed a 'tyrosine activation motif (TAM), which is 
found in several receptor subunits that associate with cyto- 
plasmic tyrosine kinases and when stimulated, are physically 
associated with and activate Src-type tyrosine kinases or Syk/ 
Zap70 which are believed to mediate the receptor signaling 
[24,25]. Although such a sequence motif is not found in the 
cytosolic domain of CD38, we cannot totally rule out the 
possibility that the short cytoplasmic domain of CD38 con- 
tains an unidentified motif that is capable of interacting with a 
cellular tyrosine kinase(s). 
We have demonstrated that CD38 ligation by selected anti- 
CD38 mAbs induces tyrosine phosphorylation f cellular pro- 
teins in human leukemia cell lines including HL-60 [11] and 
THP-1 [15] cells in their differentiated states. These cells ac- 
quire the high responsiveness to the stimulation with chemo- 
tactic receptors coupled to heterotrimeric GTP-binding pro- 
teins during the differentiation and consequently they are 
capable of generating 02-  in response to the receptor ago- 
nists. We have reported an indispensable role of PI 3-kinase in 
the chemotactic receptor-induced 02 production in granulo- 
cytes [26]. Interestingly, the receptor-induced 02-- production 
is dramatically enhanced by the simultaneous stimulation of 
CD38 by the mAbs in the same Bt2cAMP-treated THP-I cells 
(manuscript in preparation). Since the formation of intracel- 
lular PIP3, a product of PI 3-kinase, in response to chemo- 
tactic receptor stimulation is synergistically increased by the 
simultaneous addition of the agents which cause tyrosine ki- 
nase-mediated activation of PI 3-kinase [27], the augmenta- 
tion of 02-  production might be dependent on the CD38- 
mediated activation of PI 3-kinase. Our earlier finding that 
the GI]7 subunit of heterotrimeric GTP-binding proteins 
greatly increased the PI 3-kinase activity associated with tyr- 
osine-phosphorylated proteins supports the hypothesis [27]. 
Alternatively, since 02-  production requires Ca 2+ other 
than PI 3-kinase as we have indicated [28], CD38 might sup- 
ply Ca 2+ rather than PIP3 because CD38 catalyzes the forma- 
tion of cyclic ADP-ribose, which is a novel candidate for Ca 2+ 
release from intracellular Ca 2+ stores. We are currently ana- 
lyzing this in detail in our laboratories. 
During the preparation and revision of the manuscript, A. 
Kitanak et al. reported similar results showing that CD38- 
mediated tyrosine phosphorylation of Cbl is accompanied 
by its association with PI 3-kinase in human immature B- 
cell lines [29]. 
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